Roth Capital Reaffirms Aduro Biotech (ADRO) at 'Buy'; Says Partial Clinical Hold Lift No Surprise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/29/2024
Go back to Roth Capital Reaffirms Aduro Biotech (ADRO) at 'Buy'; Says Partial Clinical Hold Lift No Surprise
November 21, 2016 8:06 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
...
More